Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Multifunctional Wound Dressing with Stimuli-Responsive Drug Release and Antibacterial Action

Objectif

Chronic wounds, including pressure ulcers and burns, pose a persistent global healthcare challenge, particularly among ageing and immobilised patients. Chronic wounds frequently exhibit impaired healing, a phenomenon attributable to a complex microenvironment characterised by chronic inflammation, persistent infection, poor vascularisation, and impaired tissue regeneration. Despite the considerable advances made in the field of medicine, current wound dressings are passive and largely ineffective in responding to these multifactorial conditions. There is an absence of the capacity to dynamically adapt, monitor local changes, or deliver therapeutic agents in a controlled manner. This results in delayed healing, recurrent infections, and significant healthcare costs. WOUND-ACT proposes a novel strategy to address these limitations through the design of a smart, multi-layered and multifunctional wound dressing capable of real-time wound monitoring and stimuli-responsive therapeutic drug release. The system is composed of three distinct layers, each with a specific function: (i) an inner antibacterial GeIMA-based hydrogel with ZnO particles doped with Ag or Mg, designed to suppress microbial colonization and biofilm formation; (ii) a central electroresponsive GeIMA-based hydrogel reinforced with carbon nanotubes and therapeutic nanocapsules, enabling on-demand drug delivery triggered by wound conditions; and (iii) an outer sensing layer that uses colorimetric indicators to detect pH and temperature changes associated with infection or inflammation. This integrated platform combines diagnostics and therapy in a single modular system that is adaptable to diverse wound types, healing stages, and patient profiles. The clinical scalability of the design is of significant potential, with the capacity to reduce healing times, minimise antibiotic use, reduce readmissions and substantially reduce healthcare costs. This marks a disruptive advance in personalised wound care.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-MSCA-2025-PF

Voir tous les projets financés au titre de cet appel

Coordinateur

FUNDACION IMDEA MATERIALES
Contribution nette de l'UE
€ 194 074,56
Adresse
CALLE ERIC KANDEL 2 PARQUE CIENTIFICO Y TECNOLOGICO TECNOGETAFE
28906 Getafe
Espagne
Région
Comunidad de Madrid Comunidad de Madrid Madrid
Type d’activité
Research Organisations
Liens
Coût total
Aucune donnée